4-Chloro-6-Iodoquinazoline CAS 98556-31-1 Puritas >98.0% (HPLC)

Description:

Nomen chemicum: 4-Chloro-6-Iodoquinazoline

CAS: 98556-31-1

Puritas: >98.0% (HPLC)

Aspectus: Terra Yellow ad Yellowish-brunneis pulveris

Ditosylate Monohydratorum

Contactus: Dr

Mobile/Wechat/Whatsapp: +86-15026746401

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica 4-Chloro-6-Iodoquinazolini (CAS: 98556-31-1) cum qualitate magna.Ruifu Chemical traditio totius terrarum, quantitatis competitive pretium, optimum servitium, parvas et moles in promptu habere potest.Purchase 4-Chloro-6-Iodoquinazoline;Please contact: alvin@ruifuchem.com

Lapatinib intermedia:

Lapatinib Base	CAS 231277-92-2
Lapatinib Ditosylate Monohydrate	CAS 388082-78-8
Sodium Methanesulfinate	CAS 20277-69-4
3-Chloro-4-(3-Fluorobenzyloxy)aniline	CAS 202197-26-0
2-Aminoethyl Methyl Sulfone Hydrochloridis	CAS 104458-24-4
4-Chloro-6-Iodoquinazoline	CAS 98556-31-1
6-Iodo-4-Hydroxyquinazoline	CAS 16064-08-7
5-Formyl-2-Acidi Furanboronic	CAS 27329-70-0
5-[4-[3-Chloro-4-(3-Fluorobenzyloxy)anilino]-6-Quinazolinyl]furan-2-Carboxaldehyde	CAS 231278-84-5

Chemical Properties:

Nomen chemicum	4-Chloro-6-Iodoquinazoline
Synonyma	6-Iodo-4-Chloroquinazoline
Stock Status	In Stock, Commercial Productio
CAS Number	98556-31-1
Formulae hypotheticae	C8H4ClIN2
M. Pondus	290.49 g/mol
Liquescens punctum	175.0 ad 179.0℃
Density	2.017±0.06 g/cm3
Index refractivus n20/D	1.739
Sensitiva	Aer Sensitiva
COA & MSDS	Praesto
Origin	Shanghai, China
Brand	Ruifu Chemical

Specifications:

Items	Signa inspectionis	Proventus
Aspectus	Terra Yellow ad Yellowish-brunneis pulveris	Terra Yellow Pulvis
Liquescens punctum	175.0 ad 179.0℃	177.2℃
Damnum in Siccatio	<1.00%	0.15%
Puritas / Analysis Methodus	>98.0% (HPLC)	98.43%
1H NMR Imaginum	Congruunt Structure	Obsequitur
conclusio	Productum probatum est et cum datis specificationibus obsequitur
Applicationem	Ditosylate Monohydratorum

Sarcina / at /naviportans:

Sarcina:Fluorinated Utrem, aluminium ffoyle, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Continentem arcte clausam et in frigido, sicco et bene ventilato horreis a substantiis incompossibilibus repone.A luce et humore protege.
Naviportans:Libera ad mundum ab aere, per FedEx / DHL Express.Ieiunium et certas traditiones provide.

commoda:

Satis capacitas: sufficientes facilities et technici

Professional Service: One stop acquireing service

Altera Package: Custom sarcina ac titulus praesto

Ieiunium Delivery: Si intra stirpem, tres dies partus praestatur

Supple firmum: Esse rationabile stirpe

Technical Support: Technology solution praesto

Custom Synthesis Service: Range from P. to kilos

High Quality: Constitutus ratio completa qualitas certitudinis

FAQ:

Quam mercari?Quaeso contactumDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.
Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Coream, Iaponicam, Australiam etc.
Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.
Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.
Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.
Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.
MOQ?Nec MOQ.Parvus ordo placet.
Tempus adferendi? Si intus prosapia, tres dies partus praestatur.
Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.
Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.
Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.
Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.

98556-31-1 - Applicatio:

4-Chloro-6-Iodoquinazoline (CAS: 98556-31-1) medium est in synthesi Lapatinib (CAS: 231277-92-2) / Lapatinib Ditosylate Monohydratorum (CAS: 388082-78-8).
Lapatinib novum cancer pectoris iaculis theraphim medicamentum evolvit et fabricatum est a GlaxoSmithKline, quod ab administratione US Cibus et medicamentis die XIII Martii MMVII probatum est. Praesens probatus indicatio coniungitur cum capecitabine ad cancrum pectus provectum vel metastaticum, et aegri cancer pectus aliis medicamentis prima linea tractanda est.Nomen artis eius in Civitatibus Foederatis Americae est Tykerb.Die 14 Decembris 2007, Medicinae Europaeae Agency (EMEA) enumerationem Lapatinib in Europa sub commercii nomine Tyverb approbaverunt.Theraphim hypotheticum iaculis pro cancro mammae ad tractationem oncogenis pertinentia et expressio producta cognata ad eventum et progressionem cancri pectoris.Medicamenta hypothetica iaculis inhibent vel occidunt cellulas tumores obcludunt translationi signo in cellulis tumore vel cellulis affinibus ad mutationes in locutionibus e gene cellularum coercendis.Lapatinib est oralis augmenti minoris moleculi epidermalis factor tyrosini kinasi inhibitoris.Fuscae probationes ostenderunt pro aegris cancer pectoris HER2 qui resistentiam evolvit ad Roche Herceptin (Herceptin), Lapatinib bonum effectum clinicum habet.In vitro probat, Lapatinib notabile incrementum inhibitorium effectum in Her-2 superexpressio carcinomatis cellae lineae pectoris habuit.In Phase I tentamenta carcinomatis carcinomatis provecti cum her-2 overexpressione, Lapatinib etiam magnum ratem efficacem habet et cum Herceptin transversim non resistit (trastuzumab).Quia structura eius parva est moleculae, dissimile Herceptin (trastuzumab), obice potest penetrare sanguinem cerebri et quendam effectum medicinalem in metastasi cerebri cancri pectoris habet.